July 19, 2018

July 19, 2018

Subscribe to Latest Legal News and Analysis

July 18, 2018

Subscribe to Latest Legal News and Analysis

July 17, 2018

Subscribe to Latest Legal News and Analysis

Nine Days and Counting – The Fate of CHIP Remains Uncertain Amid Congressional Deadlock

While congressional Republicans spent much of September pushing for passage of the Graham-Cassidy “repeal and replace” bill, other time-sensitive legislative tasks were left to languish, including a September 30 deadline to reauthorize funding for the Children’s Health Insurance Program (“CHIP”) that has since come and gone. The failure to timely reauthorize the program has put the fate of CHIP in limbo, at least in the short term.

CHIP is a joint state and federal program that provides low-cost health coverage to children in families with income too high to qualify for Medicaid but too low to comfortably afford coverage. Approximately nine million children currently rely on CHIP for health coverage. Although CHIP is largely federally funded, states are also required to make contributions to, design and administer the program for its residents. Some states administer CHIP as part of their Medicaid program, other states operate CHIP as an independent program, while yet others take a combined approach.

Although the Senate Finance Committee approved a bipartisan bill on October 4th that would provide the program with more than $100 billion over five years, things did not go as smoothly in the House. The House Energy and Commerce Committee considered a similar funding bill, but the effort devolved into partisan bickering. While House Republicans indicated a willingness to provide funding, they demanded cuts and adjustments to Medicare and the ACA to offset the cost. Unsurprisingly, many Democrats balked, resulting in the Committee’s narrow approval by a vote of 28 to 23 along party lines. Because the measure lacks broad bipartisan support, members of congress and observers worry that a resolution won’t be reached prior to states’ exhaustion of emergency measures. If Congress fails to act, the Medicaid and CHIP Payment and Access Commission (“MACPAC”) estimates that more than half of states will exhaust all available CHIP funding by March 2018. The next several months should provide greater insight into the future of the program at both a state and federal level.

*Samuel Gilkeson is a Law Clerk at Sheppard Mullin in the firm’s Century City office. He contributed to this article.

Copyright © 2018, Sheppard Mullin Richter & Hampton LLP.


About this Author

Matthew Goldman, Corporate Attorney, Sheppard Mullin Law Firm

Matthew Goldman is an associate in the Corporate Practice Group in the firm's Century City office and is a member of the firm's healthcare practice team.

Areas of Practice

Matthew’s practice blends the regulatory and transactional components of healthcare law, and includes representation of hospitals, managed care organizations, medical groups, and other healthcare entities and providers. On the regulatory side, Matthew’s practice is focused on licensing, regulatory compliance, and managed care arrangements. Matthew has extensive experience preparing Knox-...

Jordan Grushkin, Attorney, Sheppard Mullin Law Firm, Health Care

Jordan Grushkin is an associate in the Corporate Practice group in the firm's Century City office.

  • J.D., Georgetown University Law Center, 2015

  • B.A., Georgetown University, 2015, magna cum laude